Clinical trials
Ananda Developments Plc has announced that its cannabis-based medicines, MRX2 (CBD) and MRX2T (CBD+THC), will be used in two major NHS-backed phase IIIa trials exploring treatments for drug-resistant epilepsy. The trials aim to test whether the medicines can reduce seizures and improve participants' quality of life in patients
Allergens
IgGenix has made significant strides in the fight against peanut allergy by announcing the initiation of its ACCELERATE Peanut Phase 1 clinical trial. The trial aims to evaluate the safety, tolerability, and potential proof of mechanism of IGNX001, a novel therapeutic candidate developed using IgGenix's proprietary SEQ SIFTER
Clinical trials
Researchers from Pfizer have made a significant discovery in the field of conjugate vaccines, developing a 20-valent pneumococcal conjugate vaccine (PCV20) to extend protection against pneumococcal disease. The phase 3 study, which has been peer-reviewed, assessed the safety and immunogenicity of PCV20 in children aged 15 months to 3 years,
Clinical trials
A new study has found that ketamine, an anesthetic medication, may be effective in treating treatment-resistant depression (TRD) in adult patients. Researchers from East London NHS Foundation Trust conducted a rapid review of existing clinical trials to evaluate the efficacy of ketamine across all formulations and routes of administration in
Cancer treatment
Fresh data from a trial evaluating the use of 5-alpha reductase inhibitors as an alternative to LHRH-agonists in treating prostate cancer has shown promising results. According to the research from the University of Chicago, men treated with 5-ARIs had better preservation of hormonal quality of life with no obvious detriment
Clinical trials
The international AIDS conference, held in Munich, Germany, from 22 to 26 July 2024, announced the results of the PURPOSE 1 trial, showcasing the 100% efficacy of lenacapavir in preventing HIV in cisgender women. These findings have significant implications for the global fight against HIV, particularly in high-risk populations. The
Clinical trials
Baptist Hospital of Miami has completed its first clinical procedure using the LIBERTY Endovascular Robotic Surgical System, a pivotal development in the Company's clinical trial. This achievement comes on the heels of the announcement that Baptist Hospital is the second clinical site to perform a procedure, following Brigham
Adults
A study published in Epilepsy Research has revealed a relationship between demographic and clinical variables and negative health events (NHEs) experienced by people with epilepsy. The research, conducted at the University of Iowa, analyzed data from a clinical trial targeting people from rural regions and underserved populations. The study found
Clinical trials
Microbot Medical, a clinical-stage medical device company, has secured Institutional Review Board (IRB) approval and partnered with Baptist Hospital of Miami to participate in the clinical trial of its innovative LIBERTY Endovascular Robotic Surgical System. This partnership marks the second announced site to join the trial, following the recent announcement
COVID-19 vaccines
As the world continues to navigate the challenges of the COVID-19 pandemic, several developments offer hope for a return to normalcy. The AstraZeneca vaccine has shown significant efficacy in preventing symptomatic COVID-19 and severe disease in a US trial, while also allaying concerns about safety and blood clots. Meanwhile, Israel
COVID-19 vaccines
The Biden administration is under fire for its handling of the migrant crisis at the US-Mexico border, with criticism coming from both Republican politicians and some in the media. Despite claims of transparency, the administration has been accused of leaving out journalists and lawmakers from access to border facilities, fueling
COVID-19 vaccines
The world is witnessing a mass effort to develop effective Covid-19 vaccines, with several promising candidates in the final stages of testing. Pfizer, Moderna, and the University of Oxford / AstraZeneca are among the leading players in the vaccine development race, with the UK's Vaccine Taskforce securing a total
